Quantitative cell signaling analysis for cetuximab sensitivity prediction in colorectal cancer

被引：0
|
作者：
Teppei, Matsuo
Nishizuka, Satoshi
Lwaya, Takeshi
Ishida, Kazushige
Noda, Hironobu
Ikeda, Miyuki
Kozai, Megumi
Wakabayashi, Go
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4146
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani, Francesco
    Cunningham, David
    LANCET ONCOLOGY, 2014, 15 (10): : 1040 - 1041
  • [32] Cetuximab for the treatment of patients with colorectal cancer
    Cassidy, J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (06): : 310 - 311
  • [33] Colorectal Cancer Panitumumab is not inferior to Cetuximab
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (09): : 1034 - 1034
  • [34] Cetuximab for treatment of metastatic colorectal cancer
    Cerea, G.
    Ricotta, R.
    Schiavetto, I.
    Maugeri, M. R.
    Sartore-Bianchi, A.
    Moroni, M.
    Artale, S.
    Siena, S.
    ANNALS OF ONCOLOGY, 2006, 17 : VII66 - VII67
  • [35] Cetuximab and colorectal cancer:: Our experience
    Berardi, E.
    Menatti, E.
    Fiumano, M.
    Fusco, O.
    Malugani, F.
    Luchena, G.
    Ardizzoia, A.
    Colombo, I
    Villa, F.
    Isa, L.
    Bolzoni, P.
    Fagnani, D.
    Bertolini, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI45 - XI45
  • [36] Cetuximab in the treatment of patients with colorectal cancer
    Garrett, Christopher R.
    Eng, Cathy
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (07) : 937 - 949
  • [37] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256
  • [38] Cetuximab in metastatic colorectal cancer Reply
    Folprecht, Gunnar
    Koehne, Claus-Henning
    LANCET ONCOLOGY, 2010, 11 (04): : 314 - 314
  • [39] Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer
    Jordi Codony-Servat
    Xabier Garcia-Albeniz
    Carles Pericay
    Vicente Alonso
    Pilar Escudero
    Carlos Fernández-Martos
    Rosa Gallego
    Anna Martínez-Cardús
    Eva Martinez-Balibrea
    Joan Maurel
    Medical Oncology, 2013, 30
  • [40] Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer
    Codony-Servat, Jordi
    Garcia-Albeniz, Xabier
    Pericay, Carles
    Alonso, Vicente
    Escudero, Pilar
    Fernandez-Martos, Carlos
    Gallego, Rosa
    Martinez-Cardus, Anna
    Martinez-Balibrea, Eva
    Maurel, Joan
    MEDICAL ONCOLOGY, 2013, 30 (01)
12345